We are live on !
Find out more
Bailard Portfolio holdings
AUM
$4.94B
Turnover
24.33%
1-Year Est. Return
25.15%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+25.15%
3 Year Est. Return
+104.94%
5 Year Est. Return
+121.63%
10 Year Est. Return
+438.61%
AUM
$640M
AUM Growth
-$7.12M
(-1.1%)
Cap. Flow
+$22.6M
Cap. Flow % of AUM
Cap. Flow %
3.54%
Top 10 Holdings %
Top 10 Hldgs %
53.7%
Holding
293
New
53
Increased
89
Reduced
80
Closed
47
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$59.2M |
| 2 |
Vanguard Total Bond Market
BND
|
+$59.1M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$19.5M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$5.19M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$58.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$58.1M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$3.59M |
| 4 |
Ryanair
RYAAY
|
+$3.57M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.01% |
| 2 | Healthcare | 6.67% |
| 3 | Technology | 6.37% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$48.1B
| $60.9M | 9.51% |
492,974
+488,144
| +10,107% | +$59.2M |
2014 Q3
4 quarters
|
|
|
2
Vanguard Total Bond Market
BND
$164B
| $59.4M | 9.28% |
+725,301
| New | +$59.1M |
2015 Q3
0 quarters
|
|
3
iShares 1-3 Year Treasury Bond ETF
SHY
$27.2B
| $59.4M | 9.28% |
699,193
+6,146
| +0.9% | +$521K |
2015 Q2
1 quarter
|
|
4
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $43.9M | 6.86% |
444,992
+24,116
| +6% | +$2.53M |
2013 Q2
9 quarters
|
|
|
5
iShares Core US Aggregate Bond ETF
AGG
$139B
| $39.7M | 6.2% |
362,328
+31,780
| +10% | +$3.47M |
2013 Q2
9 quarters
|
|
6
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.51B
| $19.8M | 3.09% |
405,924
-59,854
| -13% | -$2.91M |
2013 Q2
9 quarters
|
|
|
7
iShares MSCI Emerging Markets ETF
EEM
$29B
| $18.4M | 2.87% |
560,286
+552,581
| +7,172% | +$19.5M |
2013 Q2
9 quarters
|
|
|
8
iShares California Muni Bond ETF
CMF
$5.34B
| $16.5M | 2.58% |
280,978
+89,230
| +47% | +$5.19M |
2013 Q2
9 quarters
|
|
|
9
State Street SPDR S&P 500 ETF Trust
SPY
$817B
| $13.6M | 2.12% |
70,724
-286,468
| -80% | -$58.1M |
2013 Q2
9 quarters
|
|
10
Teva Pharmaceutical Industries Limited
TEVA
$47B
| $12.2M | 1.9% |
215,300
-35,000
| -14% | -$2.27M |
2014 Q2
5 quarters
|
|
11
Apple
AAPL
$5.06T
| $10.7M | 1.67% |
386,528
+37,428
| +11% | +$1.1M |
2013 Q2
9 quarters
|
|
|
12
Invesco QQQ Trust
QQQ
$487B
| $9.9M | 1.54% |
96,980
-545,684
| -85% | -$58.6M |
2013 Q2
9 quarters
|
|
13
iShares S&P Small-Cap 600 Value ETF
IJS
$7.69B
| $9.38M | 1.47% |
178,988
-18,520
| -9% | -$1.03M |
2013 Q2
9 quarters
|
|
14
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.98B
| $9.09M | 1.42% |
188,429
+23,203
| +14% | +$1.11M |
2013 Q4
7 quarters
|
|
15
Vanguard Information Technology ETF
VGT
$151B
| $8.15M | 1.27% |
651,640
+48,168
| +8% | +$632K |
2013 Q3
8 quarters
|
|
16
State Street Financial Select Sector SPDR ETF
XLF
$51.9B
| $7.75M | 1.21% |
389,513
+9,726
| +3% | +$206K |
2013 Q2
9 quarters
|
|
17
Vanguard Health Care ETF
VHT
$20.1B
| $6.88M | 1.08% |
56,175
+2,030
| +4% | +$278K |
2013 Q3
8 quarters
|
|
18
Vanguard Consumer Staples ETF
VDC
$7.98B
| $6.51M | 1.02% |
53,700
+1,007
| +2% | +$128K |
2013 Q3
8 quarters
|
|
19
Vanguard Consumer Discretionary ETF
VCR
$5.94B
| $6.18M | 0.97% |
52,479
+1,818
| +4% | +$225K |
2013 Q3
8 quarters
|
|
20
Vanguard Industrials ETF
VIS
$8.03B
| $4.85M | 0.76% |
51,118
+1,335
| +3% | +$136K |
2013 Q3
8 quarters
|
|
21
Alaska Air
ALK
$4.01B
| $4.54M | 0.71% |
57,080
+1,140
| +2% | +$87.1K |
2013 Q3
8 quarters
|
|
|
XL
22
DELISTED
XL Group Ltd.
XL
| $4.36M | 0.68% |
120,050
+40,050
| +50% | +$1.52M |
2015 Q2
1 quarter
|
|
23
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
| $3.9M | 0.61% |
91,411
-6,468
| -7% | -$299K |
2013 Q2
9 quarters
|
|
24
Microsoft
MSFT
$3.95T
| $3.8M | 0.59% |
85,791
+2,104
| +3% | +$94.5K |
2013 Q2
9 quarters
|
|
25
iShares MSCI ACWI ex US ETF
ACWX
$17.7B
| $3.65M | 0.57% |
93,540
+16,558
| +22% | +$697K |
2014 Q2
5 quarters
|
|
Similar funds
SL
Bailard's Q3 2015 Portfolio in Review
As of Q3 2015, Bailard held 293 positions worth $640M, down 1.1% from $647M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Bailard deployed $22.6M of net new capital in Q3 2015, opening 53 new positions and adding to 89 existing holdings. Its largest new stake was Vanguard Total Bond Market: 725,301 shares worth $59.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 70% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $58.6M trimmed.
- Bailard's largest Q3 2015 buy was Vanguard Total Bond Market: 725,301 shares worth $59.4M.
- Bailard added most to iShares 20+ Year Treasury Bond ETF in Q3 2015, an estimated $59.2M increase.
- Bailard's biggest Q3 2015 reduction was Invesco QQQ Trust, cutting an estimated $58.6M.
- Bailard fully exited Spark Therapeutics, Inc. Common Stock in Q3 2015, selling an estimated $3.59M.
- Bailard's ten largest holdings make up 54% of its $640M portfolio in Q3 2015.
- Bailard opened 53 new positions and closed 47 in Q3 2015.
- Bailard's portfolio value fell 1.1% quarter-over-quarter to $640M.
Based on Bailard's 13F filing for Q3 2015, filed 13 Nov 2015.